Leadership


总统顾问委员会

The 总统顾问委员会 (PAC) is comprised of leaders in the corporate, academic, 和非营利性部门.

该委员会的首要指令是为教育机构应该如何应对健康科学和卫生保健行业的长期趋势提供见解. 该组织每年举行两次会议.

Harvey M. Arbit,药学博士,工商管理硕士
Harvey M. Arbit, 70年制药公司.D., M.B.A.

Harvey Arbit在制药行业的监管事务领域拥有超过30年的经验, 临床研究, 质量控制, 以及产品开发. Dr. Arbit是Arbit Consulting的总裁兼首席执行官, LLC, providing regulatory strategy and support for industry, academia, and investigator-initiated sponsored 临床研究.

南希·巴伯,86年博士.D.
南希·巴伯,86年博士.D.

Nancy Barbour is senior vice president of Drug Product Science & 百时美施贵宝(Bristol-Myers Squibb)的技术部门). In this role, 她负责整个小分子管道的全球产品和工艺开发, 生物化合物, and devices. Dr. 巴伯在1991年获得B学位后加入BMS.S. 从ACPHS和Ph.D. in pharmaceutical chemistry from the University of Kansas.

丽贝卡·布兰查德博士.D.
丽贝卡·布兰查德,1990年博士.D.

Rebecca Blanchard is the Vice President of Experimental Medicine at CRISPR Therapeutics. 在加入CRISPR之前,Dr. 布兰查德是默克公司人类遗传学和药物基因组学部门的临床药物基因组学负责人. Her career in academia and in industry has spanned preclinical, 平移, and clinical development across multiple therapeutic areas.

Robert A. Blum, PHARM.D.
ROBERT A. 布鲁姆,83年的药店.D.

Robert Blum co-founded Buffalo 临床研究 Center, LLC (BCRC) in 2001. BCRC是一个先进的一期研究机构,协助制药公司进行早期药物开发. BCRC engages in a wide range of research activities including “first-time-in-man” safety, tolerability and pharmacokinetic/ pharmacodynamic studies, 生物利用度和生物等效性, 药物相互作用, 性别和食物效应研究.

Machaon Bonafede, PH.D., M.P.H.
Machaon Bonafede, PH.D., M.P.H.

Mac Bonafede是 Vice President of Research Consulting at Veradigm, an Allscripts Company. He has extensive experience in the areas of healthcare research, education, and consulting. 在加入Truven Health之前,Dr. Bonafede served on the faculty at 奥尔巴尼药学与健康科学学院, where he taught courses covering research and statistical methods, 全面质量管理, 循证医学.

David J. Carpenter, M.S., Pharm.D.
David J. 卡朋特,1881年.S., PHARM.D.

David Carpenter是执行董事, 临床研究, Evecxia Therapeutics公司, a privately funded clinical stage pharmaceutical company based in Research Triangle Park, NC. Evecxia的使命是开发和商业化的新产品,以治疗患有常见疾病的患者, 致残和昂贵的神经精神疾病,目前的治疗方法往往是次优的,以帮助那些患有精神疾病的人过得更充分, 更有意义的生活. Dr. Carpenter previously held senior leadership drug development roles at GSK, Sanofi, Dart神经科学和Roivant科学.

克里斯托弗·康威,B.S.
克里斯托弗·康威,B.S.

Christopher Conway is President at Curia Global (previously Albany Molecular Research, Inc.). 在加入Curia之前,Mr. Conway held sales, marketing, and leadership positions at Johnson & 在那里,他完成了J&J’s Leadership Development Program and received both Johnson & Johnson’s Global Standards of Leadership and Global Innovation Awards.

 

 

JOSEPH A. h3环境,制药.D., M.B.A.
Joseph A. Cordaro, 90年的制药公司.D., M.B.A.

作为副总统, 市场准入, Distribution and 病人接诊服务 at Incyte Corporation, 约瑟夫·科达罗(Joseph Cordaro)负责领导商业职能和负责支付人国民账户的现场团队, 战略客户, Distribution, 病人接诊服务, and Channel Marketing for current and future products. 在加入Incyte之前,Dr. Cordaro曾在阿斯利康担任领导职务, 罗氏制药公司, 诺华制药公司.

克里斯·达达斯,药剂师.D.
克里斯·达达斯,01年制药公司.D.

克里斯·达达斯(Chris Dadas)是副总统, 全球医疗事务副总裁, Global Head Medical Affairs at Eiger BioPharmaceuticals, Inc. His work fully integrates medical communications from many internal and external stakeholders, driving corporate research strategy and scientific direction. 在担任目前的职位之前,他曾担任过博士. Dadas served in a variety of roles at AbbieVie and Allergan, Inc.

伊曼纽尔(曼尼. Diliberto, Jr. 
伊曼纽尔(曼尼. Diliberto, Jr., '67 Ph.D. 

Dr. Diliberto has more than 44 years of academic, pharmaceutical industry, and government R&D experience. His past positions have included serving as Professor & 坎贝尔大学药学院药理学系主任 & Burroughs Wellcome公司药理学部门分子和细胞药理学部门的健康科学和小组组长.

克里斯·迪·拉西亚,制药公司.D.
克里斯·迪·拉西亚,83年制药公司.D.

Chris Di Lascia is the President, CEO, and co-founder of Transition Patient Services (TPS). 他曾任职于Aventis Pharmaceuticals,在那里他担任Lovenox的全球营销总监. 在加入先灵葆雅(Schering-Plough)担任管理医疗和政府事务经理之前,他作为Eli Lilly and Company的医院销售代表开始了他的制药行业职业生涯.

CLAYTON D. EDWARDS, R.PH., M.B.A.
Clayton D. 爱德华,公元90年.PH., M.B.A.

Clayton Edwards是AllianceRx Walgreens Prime的首席运营官,他领导着该组织近80%的员工组成的企业运营. Operations include specialty and home delivery operations​; business innovation and advanced therapies; facilities management, logistics and engineering​; service delivery and ops excellence​; plus, 运营计划与执行.

Shahrokh (seve) falati, ph.D., ESQ.
Sharokh (Seve) Falati, PH.D., ESQ.

Seve Falati是阿尔巴尼亚Falati知识产权法的注册专利律师和管理合伙人 & 在那里,他领导着一个由七名知识产权法律师组成的团队. 他的客户包括美国.S. and foreign based entities with interests in new and emerging technologies. 除了他的法律学位,他还有一个博士学位.D. 在哈佛医学院/贝斯以色列女执事医疗中心完成了三年的博士后研究.

海伦·费格,药学学士.D, mba, cphims, fhimss
Helen Figge,理学学士,药学博士,MBA, CPHIMS, FHIMSS

作为MedicaSoft的首席战略官,  Helen Figge负责帮助制定战略, build and sustain the company's reputation for quality, reliability, 以及客户满意度. 她曾担任三家财富500强公司的高管,也是健康信息管理系统协会(HIMSS)的高级领导团队成员。. 她曾四次被健康数据管理公司评为“医疗保健IT领域最具影响力的女性”之一.

THOMAS P. GARCIA, PH.D.
Thomas P. 加西亚,83年PH值.D.

Tom Garcia is a Research Fellow in the Global Chemistry, Manufacturing, 辉瑞公司(Pfizer Inc .)和控制集团(GCMC). In this role, 他与跨职能团队合作,定义开发和监管策略,生成准备和提交全球nda /MAAs所需的数据, as well as responses to regulatory queries and observations. 他职业生涯的前14年都在做工艺开发和技术转让.

贾克琳·格里马尔迪,制药公司的.D., M.S.
贾克琳·格里马尔迪,12年药剂师.D., M.S.

在获得药剂学博士学位(Pharm.D.) and M.S. ACPHS的药学专业, Jaclyn于2012年开始在Regeneron Pharmaceuticals工作,目前担任副董事, CMC项目管理. Her previous positions at Regeneron have included Senior Manufacturing Process & Technology Associate and Associate Manager, Technology Transfer.

 

FRANK L. GROSSO, B.S. PHARM., R.PH.
Frank L. 格罗索,公元前74年.S. PHARM., R.PH.

弗兰克·格罗索是 Executive Vice President Corporate Development at ActualMeds Corporation. 他有35年的长期护理药学经验, including serving as Vice President of Pharmacy Services for Genesis Healthcare, 长期护理提供者. 他在Genesis的职责包括监督411个护理中心和辅助生活社区的运营和合同药学服务. 

玛丽·格罗索,b.S. PHARM., R.PH.
玛丽·格罗索,公元前74年.S. PHARM., R.PH.

Marylee Grosso是管理合伙人, 医疗咨询, LLC, 一个独立的咨询公司,解决后急性护理提供者所面临的挑战, vendors, 以及在快速变化的监管和报销环境中的专业组织. 在担任现任职务之前, she served as Corporate Senior Director of Clinical Operations for Genesis Healthcare, 监督500多个中心的护理和医务部门的临床药学实践标准. 

斯蒂芬·赫尔斯,B.S. Pharm.
斯蒂芬·赫尔斯,公元前81年.S. Pharm.

Stephen Hulse是高级主管, 基因泰克的医疗保健市场, 世界领先的生物技术公司之一. He has 25+ years of experience in the pharmaceutical industry, including extensive management expertise at the district, regional, 以及国家层面. He is an experienced marketer of several major branded franchises, 包括国际战略发展, 以及国内业务发展倡议.

David A. Kvancz, R.PH., M.S., FASHP
David A. Kvancz, R.PH., M.S., FASHP

David Kvancz是高级副总裁, Visante的战略客户关系, a healthcare consulting firm with a focus on medication use and system optimization. 在加入维桑特公司之前,他曾担任首席执行官. Kvancz曾担任Kaiser Permanente的国家药学项目和服务副总裁, 在此之前, he was the Chief Pharmacy Officer for the Cleveland Clinic Health System.

肖恩·利兰08年药学博士
肖恩·利兰08年药学博士

Shawn Leland ’08 is the Founder and CEO of Elevation Oncology, 它成立于2019年,并于2021年上市. Shawn在医药/生物技术行业的医疗事务和业务开发方面拥有超过10年的经验. Shawn参与了礼来公司总计超过4.5亿美元的预付款和阶段性付款的全球交易, 阿瑞雅德制药, Argos Therapeutics和verasstem Oncology. 他持有ACPHS的药学学位,并通过罗格斯大学完成了Bristol Myers Squibb的行业奖学金.

STEPHEN J. MCCORMACK, PH.D.
STEPHEN J. MCCORMACK, PH.D.

Stephen McCormack is passionate about the development of medical products, technologies, 以及解决未满足医疗需求的服务. He currently serves as Managing General Partner, Exela LLC. His scientific contributions and patents include delivery of drugs to the eye, 用于治疗耳鸣的医疗器械, 还有宫颈癌的诊断测试.

医学博士阿德卡·麦金托什
阿德卡·麦金托什,96年医学博士

医学博士阿德卡·麦金托什, is a board certified Radiologist with Radiology Associates of North Texas.  He completed his medical training at Baylor College of Medicine in Houston, 然后在住院医生项目上花了几年时间, 第一次是在密歇根大学, 然后在明尼苏达大学.  The focus of his residency was general surgery and diagnostic radiology.

He completed a fellowship at Children’s Hospital of Philadelphia.  There, his sub-specialties were pediatric radiology and pediatric interventional radiology.

Ernesto Samuel,注册会计师,工商管理硕士
Ernesto Samuel,注册会计师,工商管理硕士

Ernesto Samuel has more than 35 years of global experience in cosmetic, 放射性药物的, 以及美国的制药行业, Canada, 欧洲和亚洲. Mr. Samuel previously held senior leadership positions at Syncor, INC; Pharmalogic, LLC和IBA Molecular, INC, 跨越作业区域, 质量保证, 以及监管事务. Currently, Mr. 塞缪尔是制药实验室的首席执行官, 位于奥尔巴尼的503B外包设施, NY manufacturing sterile and non-sterile medications and CEO of Biomed Innova, FDA注册实验室位于奥尔巴尼医疗中心(AMC),是AMC生物医学加速和商业化中心(BACC)的一部分。. Biomed Innova专注于新药配方, 分析测试, clinical studies and quality and regulatory consulting.

达伦·特瑞勒,89 - 90年药学博士
达伦·特瑞勒,89 - 90年药学博士

Darren Triller is Director of Strategic Initiatives at the Anticoagulation Forum, 北美最大的抗凝专家多学科成员组织(www.acforum.org). In this role, 他领导了一系列由fda资助的工作,以定义和推进抗凝血管理作为国家护理模式. He also led the recent creation and approval of a novel, ASHP-approved PGY2 pharmacy specialty residency in Thrombosis and Hemostasis Management. He has contributed to the development of national quality measures, developed an app for the periprocedural management of anticoagulants, 并发表了大量威尼斯人网站药物安全的文章.

EDWARD A. ULLMANN, R.PH., M.P.A.
EDWARD A. 乌尔曼,73年.PH., MPA

Mr. 乌尔曼带来了领导力, experience, 以及作为执行经理的技能,拥有私人和公共卫生保健行业的独特背景. 他已经开发了30多家初创公司, 并担任了16年的创始人, Chairman, President, 一家总部位于纽约的上市健康管理公司(Wellcare)的首席执行官,该公司开发和管理六家运营的卫生保健组织.